Product Information
CHLORDIAZEPOXIDE-CLIDINIUM CAP is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.2545 per EA under NDC 11534019701. Its NADAC has been published 301 times since Oct 14, 2020.
FDA first approved this application on Jul 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 2.5 mg/1; mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534019701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211421FDA Approved
7/7/2020
TE Code
AB
On Market Since
7/9/2020
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has been published 301 times since Oct 14, 2020, and over the history we have for it it has declined 77.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2545 per EA |
|---|---|
| All-time high | $15.3855 (Jan 13, 2021) |
| All-time low | $0.2088 (Apr 19, 2023) |
| 52-week high | $0.3051 |
| 52-week low | $0.2405 |
| Median price | $0.3691 |
| Average price | $1.7781 |
| Largest weekly change | +1105.5% (Nov 18, 2020) |
| Weeks tracked | 301 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHLORDIAZEPOXIDE-CLIDINIUM CAP?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPOXIDE-CLIDINIUM CAP, manufactured by Sunrise Pharmaceutical Inc., is $0.2545 per EA (NDC 11534019701), effective Aug 19, 2026.
How has the price of CHLORDIAZEPOXIDE-CLIDINIUM CAP changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has declined 77.4%. It has been tracked across 301 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPOXIDE-CLIDINIUM CAP?
Since Oct 14, 2020, the NADAC for CHLORDIAZEPOXIDE-CLIDINIUM CAP has ranged from a low of $0.2088 (Apr 19, 2023) to a high of $15.3855 (Jan 13, 2021), with a median of $0.3691 per EA.
Are there cheaper alternatives to CHLORDIAZEPOXIDE-CLIDINIUM CAP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHLORDIAZEPOXIDE-CLIDINIUM CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLORDIAZEPOXIDE-CLIDINIUM CAP?
CHLORDIAZEPOXIDE-CLIDINIUM CAP (NDC 11534019701) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.